Organizations Focus on Finding Treatments for the Rapidly Spreading Monkeypox Virus
/PRNewswire/ -- In recent weeks, there has been a drastic increase in confirmed cases of monkeypox. According to data published by the CDC, the U.S. has...
Stay updated with breaking news from Ryan Noyce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- In recent weeks, there has been a drastic increase in confirmed cases of monkeypox. According to data published by the CDC, the U.S. has...
New Jersey-based Tonix Pharmaceuticals Holding Corp. announced today a collaboration with the Kenya Medical Research Institute (KEMRI) to conduct a Phase 1 clinical study in Kenya to develop TNX-8011 as a vaccine to protect people against monkeypox and smallpox. This early-stage study is expected to start in the first half of 2023. Tonix has previously reported positive data from a monkeypox challenge clinical study in non-human primates.
Phase 1 Clinical Study Expected to be Initiated in Kenya in the First Half of 2023 World Health Organization Has Declared Monkeypox a Global Health...
Poster Presentation Includes Preclinical Data from Tonix’s Program to Develop a Vaccine for Monkeypox and Smallpox...
The TESER Act unit is a decontamination box that shines UVC light on items, like electronics, for 60 seconds to kill viruses and bacteria.